• About us
• Contact

Advertisement

Organisation › Details

AstraZeneca (Group)

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. *

 

	Start	1999-04-05 merged
	Industry	pharmaceutical
	Street	1 Francis Crick Avenue Cambridge Biomedical Campus
	City	CB2 0AA Cambridge, Cambridgeshire
		Address record changed: 2022-11-29
Basic data	Employees	I: 50,001 to 100,0 (2019-12-31)
	Currency	USD
	Annual sales	24,384,000,000 (revenue, total, consolidated (2019) 2019-12-31)
	Profit	1,227,000,000 (2019-12-31)
	Cash	5,369,000,000 (2019-12-31)
		* Document for »About Section«: AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy".
		Record changed: 2023-08-22

Advertisement

More documents for AstraZeneca (Group)

• [1] Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)"....
• [2] Capitainer AB. (1/30/23). "Press Release: Capitainer Announces Collaboration with AstraZeneca". Stockholm....
• [3] Proteros Biostructures GmbH. (5/16/22). "Press Release: Proteros Expands Oncology Collaboration and License Agreement with AstraZeneca". Munich....
• [4] Proteros Biostructures GmbH. (6/2/21). "Press Release: Proteros Enters into Oncology Collaboration and License Agreement with AstraZeneca". Martinsried....
• [5] Exscientia Ltd.. (11/10/20). "Press Release: Exscientia Recruits Industry Innovator Garry Pairaudeau as Chief Technology Officer"....
• [6] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....
• [7] AstraZeneca plc. (8/22/19). "Press Release: AstraZeneca Agrees to Buy US FDA Priority Review Voucher from Sobi"....
• [8] Abingworth LLP. (7/9/18). "Press Release: Abingworth Raises $315m for ABV VII 12th Life Sciences Fund". London....
• [9] Alexion Pharmaceuticals, Inc.. (5/25/18). "Press Release: Alexion Offer for Wilson Therapeutics Accepted". New Haven, CT....
• [10] Alexion Pharmaceuticals, Inc.. (4/11/18). "Press Release: Alexion to Acquire Wilson Therapeutics". New Haven, CT....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.